143 related articles for article (PubMed ID: 18063851)
1. Angiopoietin-like protein 3: development, analytical characterization, and clinical testing of a new ELISA.
Stejskal D; Karpísek M; Humenanská V; Solichová P; Stejskal P
Gen Physiol Biophys; 2007 Sep; 26(3):230-3. PubMed ID: 18063851
[TBL] [Abstract][Full Text] [Related]
2. Angiopoietin-like protein 4: development, analytical characterization, and clinical testing of a new ELISA.
Stejskal D; Karpísek M; Reutová H; Humenanská V; Petzel M; Kusnierová P; Vareka I; Vareková R; Stejskal P
Gen Physiol Biophys; 2008 Mar; 27(1):59-63. PubMed ID: 18436985
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor-19: development, analytical characterization and clinical evaluation of a new ELISA test.
Stejskal D; Karpísek M; Hanulová Z; Stejskal P
Scand J Clin Lab Invest; 2008; 68(6):501-7. PubMed ID: 18609104
[TBL] [Abstract][Full Text] [Related]
4. Proguanylin: development, analytical characterization, and clinical testing of a new ELISA.
Stejskal D; Solichova P; Lacnak B; Vaclavik J; Hanulova Z; Humenanska V; Sprongl L; Karpisek M
Gen Physiol Biophys; 2007 Mar; 26(1):62-5. PubMed ID: 17579256
[TBL] [Abstract][Full Text] [Related]
5. Lipocalin-2: development, analytical characterization, and clinical testing of a new ELISA.
Stejskal D; Karpísek M; Humenanska V; Hanulova Z; Stejskal P; Kusnierova P; Petzel M
Horm Metab Res; 2008 Jun; 40(6):381-5. PubMed ID: 18393169
[TBL] [Abstract][Full Text] [Related]
6. Association of soluble intercellular adhesion molecule-1 with insulin resistance and metabolic syndrome in Taiwanese.
Hsu LA; Ko YL; Wu S; Teng MS; Chou HH; Chang CJ; Chang PY
Metabolism; 2009 Jul; 58(7):983-8. PubMed ID: 19394054
[TBL] [Abstract][Full Text] [Related]
7. Higher frequency of abnormal serum angiopoietin-like protein 3 than abnormal cholesteryl ester transfer protein in Japanese hyperalphalipoproteinemic subjects.
Moon HD; Nakajima K; Kamiyama K; Takanashi K; Sakurabayashi I; Nagamine T
Clin Chim Acta; 2008 Dec; 398(1-2):99-104. PubMed ID: 18804459
[TBL] [Abstract][Full Text] [Related]
8. Plasma angiopoietin-like protein 3 (ANGPTL3) concentration is associated with uremic dyslipidemia.
Shoji T; Hatsuda S; Tsuchikura S; Kimoto E; Kakiya R; Tahara H; Koyama H; Emoto M; Tabata T; Nishizawa Y
Atherosclerosis; 2009 Dec; 207(2):579-84. PubMed ID: 19540497
[TBL] [Abstract][Full Text] [Related]
9. Leptin and insulin down-regulate angiopoietin-like protein 3, a plasma triglyceride-increasing factor.
Shimamura M; Matsuda M; Ando Y; Koishi R; Yasumo H; Furukawa H; Shimomura I
Biochem Biophys Res Commun; 2004 Sep; 322(3):1080-5. PubMed ID: 15336575
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of angiopoietin-related growth factor are increased in metabolic syndrome.
Namkung J; Koh SB; Kong ID; Choi JW; Yeh BI
Metabolism; 2011 Apr; 60(4):564-8. PubMed ID: 20673930
[TBL] [Abstract][Full Text] [Related]
11. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors.
Quijada Z; Paoli M; Zerpa Y; Camacho N; Cichetti R; Villarroel V; Arata-Bellabarba G; Lanes R
Pediatr Diabetes; 2008 Oct; 9(5):464-71. PubMed ID: 18507788
[TBL] [Abstract][Full Text] [Related]
12. Determination of serum zinc-alpha-2-glycoprotein in patients with metabolic syndrome by a new ELISA.
Stejskal D; Karpísek M; Reutová H; Stejskal P; Kotolová H; Kollár P
Clin Biochem; 2008 Mar; 41(4-5):313-6. PubMed ID: 18078816
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
[TBL] [Abstract][Full Text] [Related]
14. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
Hung J; McQuillan BM; Thompson PL; Beilby JP
Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
[TBL] [Abstract][Full Text] [Related]
15. Angiopoietin-like protein 3 and adiponectin levels in patients with metabolic syndrome.
Guo W; Che Z; Xu A; Zhou Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Mar; 35(3):203-8. PubMed ID: 20360639
[TBL] [Abstract][Full Text] [Related]
16. Selenium intake reduces serum C3, an early marker of metabolic syndrome manifestations, in healthy young adults.
Puchau B; Zulet MA; González de Echávarri A; Navarro-Blasco I; Martínez JA
Eur J Clin Nutr; 2009 Jul; 63(7):858-64. PubMed ID: 18985060
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy.
Oike Y; Akao M; Kubota Y; Suda T
Trends Mol Med; 2005 Oct; 11(10):473-9. PubMed ID: 16154386
[TBL] [Abstract][Full Text] [Related]
18. ANGPTL3 is increased in both insulin-deficient and -resistant diabetic states.
Inukai K; Nakashima Y; Watanabe M; Kurihara S; Awata T; Katagiri H; Oka Y; Katayama S
Biochem Biophys Res Commun; 2004 May; 317(4):1075-9. PubMed ID: 15094378
[TBL] [Abstract][Full Text] [Related]
19. A-FABP--a biomarker associated with the metabolic syndrome and/or an indicator of weight change?
Engl J; Ciardi C; Tatarczyk T; Kaser S; Laimer M; Laimer E; Weiss H; Aigner F; Molnar C; Tilg H; Patsch JR; Ebenbichler CF
Obesity (Silver Spring); 2008 Aug; 16(8):1838-42. PubMed ID: 18535557
[TBL] [Abstract][Full Text] [Related]
20. Impacts of angiopoietin-like proteins on lipoprotein metabolism and cardiovascular events.
Miida T; Hirayama S
Curr Opin Lipidol; 2010 Feb; 21(1):70-5. PubMed ID: 19851103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
